Sign in

CIK 0000897448 · Accelerated filer

AMARIN CORP PLCUK

Sign in to watch
Ticker
AMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
353 1 6699 020
Business address
SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
Former names
AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Option exercise EVP, President US acquired 12,733 shares (option exercise)
  6. 4 Shares withheld for taxes SVP and CFO gave up 5,317 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,121 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Option exercise EVP, President US acquired 47,767 shares (option exercise)
  11. 4 Shares withheld for taxes SVP and CFO gave up 25,379 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 24,433 shares (to pay taxes)
  13. 4 Shares withheld for taxes President and CEO gave up 3,876 shares (to pay taxes)
  14. 4 Open-market buy Director bought 12,000 shares at an average $3.25 ($38,999)
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes EVP, President US gave up 3,011 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP and CFO gave up 3,011 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 3,127 shares (to pay taxes)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale SVP and CFO sold 120,000 shares at $5.25 ($630,240)

Page 8 of 31 · 620 filings